{"name":"IRCCS Fondazione Stella Maris","slug":"irccs-fondazione-stella-maris","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE9ZWnF1Q0pBRlhUbjdhdnFFRDFFbHlWeTRTVzhPYzR1cV91S01jdE1Ka21mQnBkZXVqcDBRbHZFdFliYUg1c2M4bUxaN1A5dEZyV1pLc0lMaDA1TjJuODE1RE53?oc=5","date":"2025-08-07","type":"pipeline","source":"ACS Publications","summary":"Polydopamine Nanoparticles as a Potential Non-Pharmaceutical Antioxidant Tool against Mitochondrial Disorders - ACS Publications","headline":"Polydopamine Nanoparticles as a Potential Non-Pharmaceutical Antioxidant Tool against Mitochondrial Disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxOT3NQdEd6bTJONzZNanVoV0xXcmZzOWdnUHZIRGVPOUs4RkpUb1ZyekdFdHJwY0FLREd1a3dueUFEWkN3cFdxVHE1TTk2cExEdXRnNExXTV9PdGJjRTg3NEExWmdpbnFLcXpoQV9MMHg1YUQ0UWFWRkYwbVZOaDVrLXRkaXAtV19DbThoQ3FoWEczTE9WMzBEck9EU25jNWt5WlhlSjBxRHpVNF9odjRlUDB1Q1pnYm0xNTVuVTI4N0xWd0lhQWFSV1hTaWpzSlh1RFhVNkVfRGRFM1EwUm0zcFlXNjVNWFQxQXpwSkFLbXJicnktd2RlcQ?oc=5","date":"2025-03-03","type":"pipeline","source":"Ricerca Malattie Genetiche Rare","summary":"A platform dedicated to Duchenne Muscular Dystrophy - Ricerca Malattie Genetiche Rare","headline":"A platform dedicated to Duchenne Muscular Dystrophy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}